These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 20417647

  • 1. In vitro concentration dependent transport of phenytoin and phenobarbital, but not ethosuximide, by human P-glycoprotein.
    Zhang C, Kwan P, Zuo Z, Baum L.
    Life Sci; 2010 Jun 05; 86(23-24):899-905. PubMed ID: 20417647
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Potential role for human P-glycoprotein in the transport of lacosamide.
    Zhang C, Chanteux H, Zuo Z, Kwan P, Baum L.
    Epilepsia; 2013 Jul 05; 54(7):1154-60. PubMed ID: 23551115
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. P-glycoprotein-mediated efflux of phenobarbital at the blood-brain barrier evidence from transport experiments in vitro.
    Yang ZH, Liu XD.
    Epilepsy Res; 2008 Jan 05; 78(1):40-9. PubMed ID: 18063342
    [Abstract] [Full Text] [Related]

  • 6. P-Glycoprotein expression in human retinal pigment epithelium cell lines.
    Constable PA, Lawrenson JG, Dolman DE, Arden GB, Abbott NJ.
    Exp Eye Res; 2006 Jul 05; 83(1):24-30. PubMed ID: 16530756
    [Abstract] [Full Text] [Related]

  • 7. Functional assessment of multiple P-glycoprotein (P-gp) probe substrates: influence of cell line and modulator concentration on P-gp activity.
    Taub ME, Podila L, Ely D, Almeida I.
    Drug Metab Dispos; 2005 Nov 05; 33(11):1679-87. PubMed ID: 16093365
    [Abstract] [Full Text] [Related]

  • 8. Assessment of antiepileptic drugs as substrates for canine P-glycoprotein.
    West CL, Mealey KL.
    Am J Vet Res; 2007 Oct 05; 68(10):1106-10. PubMed ID: 17916018
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Characterization of P-glycoprotein inhibition by major cannabinoids from marijuana.
    Zhu HJ, Wang JS, Markowitz JS, Donovan JL, Gibson BB, Gefroh HA, Devane CL.
    J Pharmacol Exp Ther; 2006 May 05; 317(2):850-7. PubMed ID: 16439618
    [Abstract] [Full Text] [Related]

  • 12. Differences in the transport of the antiepileptic drugs phenytoin, levetiracetam and carbamazepine by human and mouse P-glycoprotein.
    Baltes S, Gastens AM, Fedrowitz M, Potschka H, Kaever V, Löscher W.
    Neuropharmacology; 2007 Feb 05; 52(2):333-46. PubMed ID: 17045309
    [Abstract] [Full Text] [Related]

  • 13. Resistance to antiepileptic drugs and expression of P-glycoprotein in two rat models of status epilepticus.
    Bankstahl JP, Löscher W.
    Epilepsy Res; 2008 Nov 05; 82(1):70-85. PubMed ID: 18760905
    [Abstract] [Full Text] [Related]

  • 14. Effect of 21-day exposure of phenobarbital, carbamazepine and phenytoin on P-glycoprotein expression and activity in the rat brain.
    Wen T, Liu YC, Yang HW, Liu HY, Liu XD, Wang GJ, Xie L.
    J Neurol Sci; 2008 Jul 15; 270(1-2):99-106. PubMed ID: 18440557
    [Abstract] [Full Text] [Related]

  • 15. P-glycoprotein efflux at the blood-brain barrier mediates differences in brain disposition and pharmacodynamics between two structurally related neurokinin-1 receptor antagonists.
    Smith BJ, Doran AC, McLean S, Tingley FD, O'Neill BT, Kajiji SM.
    J Pharmacol Exp Ther; 2001 Sep 15; 298(3):1252-9. PubMed ID: 11504828
    [Abstract] [Full Text] [Related]

  • 16. Blood-brain barrier cell line PBMEC/C1-2 possesses functionally active P-glycoprotein.
    Neuhaus W, Stessl M, Strizsik E, Bennani-Baiti B, Wirth M, Toegel S, Modha M, Winkler J, Gabor F, Viernstein H, Noe CR.
    Neurosci Lett; 2010 Jan 22; 469(2):224-8. PubMed ID: 19963040
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of the permeability and P-glycoprotein efflux of carbamazepine and several derivatives across mouse small intestine by the Ussing chamber technique.
    Fortuna A, Alves G, Falcão A, Soares-da-Silva P.
    Epilepsia; 2012 Mar 22; 53(3):529-38. PubMed ID: 22372629
    [Abstract] [Full Text] [Related]

  • 18. Role of P-glycoprotein in accumulation and cytotoxicity of amrubicin and amrubicinol in MDR1 gene-transfected LLC-PK1 cells and human A549 lung adenocarcinoma cells.
    Hira A, Watanabe H, Maeda Y, Yokoo K, Sanematsu E, Fujii J, Sasaki J, Hamada A, Saito H.
    Biochem Pharmacol; 2008 Feb 15; 75(4):973-80. PubMed ID: 18054347
    [Abstract] [Full Text] [Related]

  • 19. Pluronic P85 enhances the delivery of digoxin to the brain: in vitro and in vivo studies.
    Batrakova EV, Miller DW, Li S, Alakhov VY, Kabanov AV, Elmquist WF.
    J Pharmacol Exp Ther; 2001 Feb 15; 296(2):551-7. PubMed ID: 11160643
    [Abstract] [Full Text] [Related]

  • 20. In vitro transport assays of rufinamide, pregabalin, and zonisamide by human P-glycoprotein.
    Chan PS, Zhang C, Zuo Z, Kwan P, Baum L.
    Epilepsy Res; 2014 Mar 15; 108(3):359-66. PubMed ID: 24530088
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.